Related Experiment Video
Updated: Oct 15, 2025
06:48
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
2.5K
Current and future treatment approaches for Barth syndrome
Reid Thompson1, John Jefferies2, Suya Wang3
1Department of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Journal of Inherited Metabolic Disease
|October 29, 2021
Summary
Barth Syndrome, a genetic disorder affecting cardiolipin metabolism, is being studied with new treatments targeting mitochondrial issues. Clinical trials are exploring elamipretide and bezafibrate to address the underlying biochemical defect.
Area of Science:
- Biochemistry
- Genetics
- Mitochondrial Medicine
Background:
- Barth Syndrome is an X-linked disorder impacting cardiolipin metabolism due to TAFAZZIN gene variants.
- It presents with diverse symptoms including cardiomyopathy, neutropenia, growth delay, and skeletal myopathy.
- Current management focuses on symptoms, not the root biochemical cause.
Purpose of the Study:
- To investigate novel therapeutic strategies for Barth Syndrome.
- To evaluate treatments targeting the mitochondrial pathology and underlying biochemical defect.
Main Methods:
- Clinical trials assessing elamipretide, a cardiolipin-targeted agent.
- Clinical trials assessing bezafibrate, a peroxisome proliferator-activated receptor (PPAR) agonist.
Main Results:
- Elamipretide and bezafibrate trials are underway to assess their efficacy.
- Further research is exploring enzyme and gene therapies for the TAFAZZIN pathway.
Conclusions:
- New therapeutic avenues are emerging for Barth Syndrome, moving beyond symptomatic treatment.
- Targeting mitochondrial dysfunction and the TAFAZZIN pathway offers potential for disease remediation.
More Related Videos
Related Concept Videos
01:21Barrett Esophagus-II: Clinical Manifestations and Management
345
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
345
01:21Barrett Esophagus-I: Introduction
257
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
257
01:29Chronic Pancreatitis II: Collaborative Care
141
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
141
01:27Peripheral Artery Disease III: Interprofessional Care
56
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
56
01:28Esophageal Varices-II: Clinical Features and Management
173
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
173
01:26Esophageal Strictures-II: Clinical Features and Management
187
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
187